Related Experiment Video
Updated: Dec 17, 2025
08:36
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
1.0K
Clinical trials with sequential analysis that were early-stopped: How to interpret them?
Luis Ignacio Garegnani1, Marcelo Arancibia2, Eva Madrid2
1Departamento de Investigación, Centro Cochrane Asociado, Instituto Universitario Hospital Italiano, Buenos Aires, Argentina.
Medwave
|July 1, 2020
Summary
Sequential analysis in clinical trials offers continuous data monitoring for participant safety and error rate control. However, this method presents challenges like effect size overestimation and conditional bias, impacting systematic reviews.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Evidence Synthesis
Background:
- Sequential analysis enables continuous monitoring of clinical trial data.
- It enhances participant safety by halting trials early if a therapy is clearly inferior.
- The method aims to control the overall error rate.
Purpose of the Study:
- To review the methodology of sequential analysis in clinical trials.
- To discuss the challenges associated with sequential analysis, including safety-efficacy balance and bias.
- To evaluate the impact of early-stopped trials on systematic reviews and meta-analyses.
Main Methods:
- Literature review of sequential analysis in clinical trials.
- Discussion of statistical considerations and potential biases.
- Analysis of the integration of early-stopped trials into meta-analysis.
Main Results:
- Sequential analysis provides benefits in trial monitoring and participant protection.
- Key issues include balancing safety and efficacy, overestimating effect sizes, and conditional bias.
- Early stopping can influence the results of subsequent meta-analyses.
Conclusions:
- Sequential analysis is a valuable tool but requires careful application due to inherent challenges.
- Researchers must be aware of potential biases and their impact on evidence synthesis.
- Further research is needed to optimize the use of early-stopped trials in systematic reviews.
Related Concept Videos
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:11Clinical Trials: Overview
4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
316
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
316
01:18Introduction To Survival Analysis
628
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
628
01:15Assumptions of Survival Analysis
307
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
307
01:20Comparing the Survival Analysis of Two or More Groups
474
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
474